BIM
INSY

Bogle Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Bogle Investment Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-588,351
Closed -$7.59M – 425
2013
Q4 		$7.59M Buy
588,351
+198,708
+51% +$2.76M 0.64% 63
2013
Q3 		$4.54M Buy
+389,643
New +$3.2M 0.46% 83

Other funds holding INSY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bogle Investment Management's INSY Position: Q1 2014 in Review

Bogle Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q1 2014, closing a stake of 588,351 shares — an estimated $7.59M sold.

Bogle Investment Management first reported a position in INSY in Q3 2013 and held it in 2 quarters. The position peaked at $7.59M in Q4 2013. 99 funds tracked by Wall St. Rank hold INSY as of Q1 2014.

  • Bogle Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q1 2014 after selling out during the quarter.
  • Bogle Investment Management sold 588,351 Insys Therapeutics, Inc. shares in Q1 2014, an estimated $7.59M.
  • Bogle Investment Management first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 2 quarters.
  • Bogle Investment Management's Insys Therapeutics, Inc. position peaked at $7.59M in Q4 2013.
  • 99 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2014.

Based on Bogle Investment Management's 13F filing for Q1 2014, filed 14 May 2014.